Back to Search Start Over

Cholecystokinin Receptor Antagonist Halts Progression of Pancreatic Cancer Precursor Lesions and Fibrosis in Mice

Authors :
Smith, Jill P.
Cooper, Timothy K.
McGovern, Christopher O.
Gilius, Evan L.
Zhong, Qing
Liao, Jiangang
Molinolo, Alfredo A.
Gutkind, J. Silvio
Matters, Gail L.
Source :
Pancreas; October 2014, Vol. 43 Issue: 7 p1050-1059, 10p
Publication Year :
2014

Abstract

Exogenous administration of cholecystokinin (CCK) induces hypertrophy and hyperplasia of the pancreas with an increase in DNA content. We hypothesized that endogenous CCK is involved in the malignant progression of pancreatic intraepithelial neoplasia (PanIN) lesions and the fibrosis associated with pancreatic cancer.

Details

Language :
English
ISSN :
08853177 and 15364828
Volume :
43
Issue :
7
Database :
Supplemental Index
Journal :
Pancreas
Publication Type :
Periodical
Accession number :
ejs48753532
Full Text :
https://doi.org/10.1097/MPA.0000000000000194